Comparison

ACE-083 European Partner

Item no. TMO-T202706-50mg
Manufacturer TargetMol
CASRN 81080-10-6
Amount 50 mg
Quantity options 10 mg 10 mg 50 mg 50 mg
Category
Type Molecules
Specific against other
Smiles O=C(NC=1C=C(C(O)=C(C1)CN2CCCCC2)CN3CCCCC3)C
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias ACE083,ACE 083
Shipping Condition Cool pack
Available
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
345, 48
Description
ACE-083 is a follistatin-based therapeutic agent known for its localized mechanism of action. It works by binding to myostatin and other muscle-regulating factors to enhance muscle mass. ACE-083 has undergone testing in various clinical trials for different neuromuscular diseases, yielding mixed results. Notably, in a Phase 2 clinical trial for FSHD, it increased muscle volume, but did not improve function, leading to the discontinuation of its use for FSHD treatment.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close